Konuma, Takaaki <br/><br/>
Reduced-Toxicity Myeloablative Conditioning Consisting of Fludarabine/Busulfan/Low-Dose Total Body Irradiation/Granulocyte Colony-Stimulating Factor-Combined Cytarabine in Single Cord Blood Transplantation for Elderly Patients with Nonremission Myeloid Malignancies.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  04 2019 
 - 764-770 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2018.12.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Busulfan--pharmacology<br/>Cord Blood Stem Cell Transplantation--methods<br/>Cytarabine--pharmacology<br/>Female<br/>Granulocyte Colony-Stimulating Factor--pharmacology<br/>Humans<br/>Male<br/>Middle Aged<br/>Myeloablative Agonists--pharmacology<br/>Myelodysplastic Syndromes--drug therapy<br/>Vidarabine--analogs & derivatives<br/>Whole-Body Irradiation--methods